How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

  • Question on Document

    Are there any implementation considerations for digital technologies for supporting self-management of COPD that we may have missed?
  • Question on Document

    Please let us know of any other ongoing studies with the technologies to include in table 1
The content on this page is not current guidance and is only for the purposes of the consultation process.

5 Minimum evidence standards

All the technologies that have been recommended for use in the NHS while more evidence is generated have some clinical evidence suggesting that they may improve symptoms of COPD, enhance respiratory function, and reduce exacerbations. None of the technologies reported any safety concerns when using the digital technologies to support self-management of COPD.

In addition to the evidence above, the committee has indicated that it may be able to recommend technologies in this topic area in the future that have evidence for:

  • a beneficial impact of the digital technologies compared with standard self-management of COPD without digital technologies

  • long-term clinical improvement in COPD using COPD Assessment Test (CAT) score and the number of exacerbations

  • resource use associated with the technologies and NHS standard care

  • intervention acceptance, completion rates, patient preference, and uptake rates

  • adverse events.

Companies can strengthen the evidence base by also having evidence for:

  • effects on health-related quality of life measured through the EQ-5D-3L

  • effectiveness in different subgroups

  • where the technologies are used in the care pathway.